
Celeste A. Roney
Examiner (ID: 16321, Phone: (571)272-5192 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612 |
| Total Applications | 882 |
| Issued Applications | 480 |
| Pending Applications | 120 |
| Abandoned Applications | 306 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10692368
[patent_doc_number] => 20160038515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-11
[patent_title] => 'METHODS AND COMPOSITIONS FOR ENHANCING OXYGEN LEVELS IN TISSUES'
[patent_app_type] => utility
[patent_app_number] => 14/776671
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4947
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776671
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/776671 | Methods and compositions for enhancing oxygen levels in tissues | Mar 13, 2014 | Issued |
Array
(
[id] => 10677972
[patent_doc_number] => 20160024118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'COPPER (I) COMPLEXES WITH GLYCINE, PYRUVATE, AND SUCCINATE'
[patent_app_type] => utility
[patent_app_number] => 14/773289
[patent_app_country] => US
[patent_app_date] => 2014-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 8279
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14773289
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/773289 | COPPER (I) COMPLEXES WITH GLYCINE, PYRUVATE, AND SUCCINATE | Mar 6, 2014 | Abandoned |
Array
(
[id] => 9756323
[patent_doc_number] => 20140287024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'NANOPARTICLE-BASED DELIVERY SYSTEM WITH OXIDIZED PHOSPHOLIPIDS AS TARGETING LIGANDS FOR THE PREVENTION, DIAGNOSIS AND TREATMENT OF ATHEROSCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 14/198481
[patent_app_country] => US
[patent_app_date] => 2014-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 16848
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14198481
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/198481 | NANOPARTICLE-BASED DELIVERY SYSTEM WITH OXIDIZED PHOSPHOLIPIDS AS TARGETING LIGANDS FOR THE PREVENTION, DIAGNOSIS AND TREATMENT OF ATHEROSCLEROSIS | Mar 4, 2014 | Abandoned |
Array
(
[id] => 10662230
[patent_doc_number] => 20160008375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'PHARMACEUTICAL FORMULATIONS COMPRISING QUETIAPINE AND ESCITALOPRAM'
[patent_app_type] => utility
[patent_app_number] => 14/771692
[patent_app_country] => US
[patent_app_date] => 2014-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2427
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14771692
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/771692 | PHARMACEUTICAL FORMULATIONS COMPRISING QUETIAPINE AND ESCITALOPRAM | Feb 26, 2014 | Abandoned |
Array
(
[id] => 10553874
[patent_doc_number] => 09278068
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-08
[patent_title] => 'Vesicle compositions'
[patent_app_type] => utility
[patent_app_number] => 14/177129
[patent_app_country] => US
[patent_app_date] => 2014-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 21
[patent_no_of_words] => 9817
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14177129
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/177129 | Vesicle compositions | Feb 9, 2014 | Issued |
Array
(
[id] => 10412716
[patent_doc_number] => 20150297726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'SUSTAINED-RELEASE LIPID PRE-CONCENTRATE OF GNRH ANALOGUES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/440060
[patent_app_country] => US
[patent_app_date] => 2013-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6161
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14440060
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/440060 | Sustained-release lipid pre-concentrate of GNRH analogues and pharmaceutical composition comprising the same | Dec 26, 2013 | Issued |
Array
(
[id] => 9396151
[patent_doc_number] => 20140093557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-03
[patent_title] => 'EXOSOMAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/107691
[patent_app_country] => US
[patent_app_date] => 2013-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 19861
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14107691
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/107691 | EXOSOMAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE | Dec 15, 2013 | Abandoned |
Array
(
[id] => 10450592
[patent_doc_number] => 20150335606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'Gel Compositions'
[patent_app_type] => utility
[patent_app_number] => 14/652091
[patent_app_country] => US
[patent_app_date] => 2013-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11771
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14652091
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/652091 | Gel Compositions | Dec 10, 2013 | Abandoned |
Array
(
[id] => 10435666
[patent_doc_number] => 20150320678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-12
[patent_title] => 'GEL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/652088
[patent_app_country] => US
[patent_app_date] => 2013-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13981
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14652088
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/652088 | GEL COMPOSITIONS | Dec 10, 2013 | Abandoned |
Array
(
[id] => 12008576
[patent_doc_number] => 09801874
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-31
[patent_title] => 'Method for the preparation of liposome encapsulated vincristine for therapeutic use'
[patent_app_type] => utility
[patent_app_number] => 14/646359
[patent_app_country] => US
[patent_app_date] => 2013-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9444
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14646359
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/646359 | Method for the preparation of liposome encapsulated vincristine for therapeutic use | Nov 19, 2013 | Issued |
Array
(
[id] => 9371005
[patent_doc_number] => 20140080878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-20
[patent_title] => 'HEPARANASE ACTIVITY INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 14/082440
[patent_app_country] => US
[patent_app_date] => 2013-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6149
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14082440
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/082440 | Heparanase activity inhibitor | Nov 17, 2013 | Issued |
Array
(
[id] => 9537096
[patent_doc_number] => 20140161743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'DENTIFRICE COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 14/069184
[patent_app_country] => US
[patent_app_date] => 2013-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4917
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14069184
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/069184 | Dentifrice composition | Oct 30, 2013 | Issued |
Array
(
[id] => 10387845
[patent_doc_number] => 20150272852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'LUBRICATING RESIN COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 14/440524
[patent_app_country] => US
[patent_app_date] => 2013-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9338
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14440524
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/440524 | LUBRICATING RESIN COMPOSITION | Oct 27, 2013 | Abandoned |
Array
(
[id] => 9943670
[patent_doc_number] => 08992969
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-31
[patent_title] => 'Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery'
[patent_app_type] => utility
[patent_app_number] => 14/059369
[patent_app_country] => US
[patent_app_date] => 2013-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 6718
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14059369
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/059369 | Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery | Oct 20, 2013 | Issued |
Array
(
[id] => 9864273
[patent_doc_number] => 20150044292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-12
[patent_title] => 'BIPHASIC LIPID-VESICLE COMPOSITIONS AND METHODS FOR TREATING CERVICAL DYSPLASIA BY INTRAVAGINAL DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 14/059373
[patent_app_country] => US
[patent_app_date] => 2013-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6698
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14059373
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/059373 | Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery | Oct 20, 2013 | Issued |
Array
(
[id] => 10373079
[patent_doc_number] => 20150258085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'Treating Tumors of the Central Nervous System'
[patent_app_type] => utility
[patent_app_number] => 14/435719
[patent_app_country] => US
[patent_app_date] => 2013-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7799
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435719
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/435719 | Treating Tumors of the Central Nervous System | Oct 17, 2013 | Abandoned |
Array
(
[id] => 10405084
[patent_doc_number] => 20150290094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-15
[patent_title] => 'SURFACE-TREATED SPHERICAL CALCIUM CARBONATE PARTICLES FOR COSMETICS AND METHOD FOR PRODUCING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/436322
[patent_app_country] => US
[patent_app_date] => 2013-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6556
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436322
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/436322 | Surface-treated spherical calcium carbonate particles for cosmetics and method for producing same | Oct 15, 2013 | Issued |
Array
(
[id] => 10361131
[patent_doc_number] => 20150246137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'LIPID COATED NANOPARTICLES CONTAINING AGENTS HAVING LOW AQUEOUS AND LIPID SOLUBILITIES AND METHODS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/431516
[patent_app_country] => US
[patent_app_date] => 2013-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 46197
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14431516
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/431516 | LIPID COATED NANOPARTICLES CONTAINING AGENTS HAVING LOW AQUEOUS AND LIPID SOLUBILITIES AND METHODS THEREOF | Sep 25, 2013 | Abandoned |
Array
(
[id] => 11242661
[patent_doc_number] => 09468688
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-18
[patent_title] => 'Boron cluster-modified PEG lipid derivative, and molecular assembly using same'
[patent_app_type] => utility
[patent_app_number] => 14/423049
[patent_app_country] => US
[patent_app_date] => 2013-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 14
[patent_no_of_words] => 5689
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14423049
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/423049 | Boron cluster-modified PEG lipid derivative, and molecular assembly using same | Aug 21, 2013 | Issued |
Array
(
[id] => 10331794
[patent_doc_number] => 20150216799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'PREPARATION OF DESICCATED LIPOSOMES FOR USE IN COMPRESSIBLE DELIVERY SYSTEMS'
[patent_app_type] => utility
[patent_app_number] => 14/412019
[patent_app_country] => US
[patent_app_date] => 2013-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6443
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14412019
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/412019 | Preparation of desiccated liposomes for use in compressible delivery systems | Aug 15, 2013 | Issued |